At a glance
ClinicalIndex Comparison RecordN/ACompleted· 250 enrolled
Drug / intervention
Insulin Pump with Continuous Glucose Monitoringdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety and Effectiveness Evaluation of the MiniMed™ 780G System Used in Combination With the DS5 CGM
In Brief
A clinical study evaluating Insulin Pump with Continuous Glucose Monitoring for Type 1 Diabetes. Completed, enrolled 250 participants across 23 sites.
Detailed Summary
The purpose of this study is to confirm the safety and effectiveness of the MiniMed 780G insulin pump used in combination with the DS5 CGM in type 1 diabetes adult and pediatric subjects in a home setting.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202420252026
First PostedFeb 2023
Enrollment StartFeb 2023
Primary CompletionDec 2023
TodayJul 2026
First PostedFeb 6, 2023
Enrollment StartFeb 28, 2023
Primary CompletionDec 29, 2023
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 3.4 years ago
Interventions
Insulin Pump with Continuous Glucose Monitoringdevice
MiniMed™ 780G insulin pump in combination with the DS5 CGM